Analyzing the Price-to-Earnings Ratio of OKYO Pharma Limited (OKYO)

The 36-month beta value for OKYO is also noteworthy at 0.14.

The public float for OKYO is 18.42M, and at present, short sellers hold a 0.28% of that float. The average trading volume of OKYO on February 13, 2024 was 2.07 shares.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

OKYO) stock’s latest price update

The stock price of OKYO Pharma Limited (NASDAQ: OKYO) has jumped by 1.45 compared to previous close of 6.00. Despite this, the company has seen a gain of 9.85% in its stock price over the last five trading days. Proactive Investors reported 2024-02-09 that OKYO Pharma Ltd (NASDAQ:OKYO) shares moved higher ahead of Friday’s opening bell after the biopharmaceutical firm announced that the US Food and Drug Administration (FDA) has cleared its first Investigational New Drug (IND) application for its drug candidate OK-101 for the treatment of neuropathic corneal pain. The company can now progress with a Phase 2 study comparing OK-101 to placebo in neuropathic corneal pain patients which is scheduled to begin in the second quarter of 2024.

OKYO’s Market Performance

OKYO Pharma Limited (OKYO) has seen a 9.85% rise in stock performance for the week, with a -14.20% decline in the past month and a -17.14% plunge in the past quarter. The volatility ratio for the week is 15.44%, and the volatility levels for the past 30 days are at 9.08% for OKYO.

OKYO 50-Day Moving Average

After a stumble in the market that brought OKYO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.29% of loss for the given period.

Volatility was left at 9.08%, however, over the last 30 days, the volatility rate increased by 15.44%, as shares sank -16.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.45% lower at present.

During the last 5 trading sessions, OKYO rose by +9.85%, which changed the moving average for the period of 200-days by +14.17% in comparison to the 20-day moving average, which settled at $1.5373. In addition, OKYO Pharma Limited saw -18.08% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at OKYO starting from BRANCACCIO JOHN P, who purchase 16,670 shares at the price of $1.50 back on Sep 15. After this action, BRANCACCIO JOHN P now owns 16,670 shares of OKYO Pharma Limited, valued at $25,005 using the latest closing price.


In summary, OKYO Pharma Limited (OKYO) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”.

Related Posts